As the pharmaceutical industry faces increasing scrutiny and regulatory changes, the pressure to find safe and effective alternatives to commonly used ingredients like titanium dioxide (TiO2) has never been higher. With its widespread use as a white colorant and opacifier in hard capsules, the removal of TiO2 presents both technical and regulatory challenges. Companies must adapt to changing global regulations while ensuring product stability, efficacy, and safety, which can impact the bottom line and public perception.
In this webinar, our experts will walk you through the latest regulatory updates surrounding the use of TiO2 in pharmaceutical formulations. We will explore the complexities of replacing TiO2 in hard capsules, detailing the technical considerations involved, from maintaining opacity and color consistency to preserving product performance. You will gain valuable insights into alternative solutions, including the latest advancements in capsules designed to meet the demands of modern pharmaceutical manufacturing.
By attending this session, you’ll learn how to navigate these regulatory shifts while developing strategies for successful TiO2 replacement. Our presentation will provide practical tips and case studies to help you adapt your products to meet both compliance requirements and consumer expectations.
Don't miss this opportunity to stay ahead of industry changes. Register now to learn how your company can embrace this transition and remain competitive in the evolving pharmaceutical landscape.
Key Learning Objectives
- Understand the latest regulatory guidelines and their impact on TiO2 use in pharmaceuticals.
- Identify technical challenges and considerations for replacing TiO2 in hard capsules while maintaining performance.
- Explore effective alternative solutions to TiO2 for achieving opacity and color consistency in capsules.
